Allschwil
Switzerland
13
2025-09-11
The entities that hold a legal rights for patent applications filed by inventor DINGEMANSE Jasper:
Jasper DINGEMANSE from Allschwil, CH has applied for patents for these inventions. The list has both pending applications and granted patents:
DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST
#2 | 2023-04-27DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST
#3 | 2023-01-05Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
#4 | 2021-12-30DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST
#5 | 2021-02-25Dosing regimen for a selective S1Preceptor agonist
#6 | 2019-10-24Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
#7 | 2019-05-23Dosing regimen for a selective S1Preceptor agonist
#8 | 2018-05-31Dosing regimen for a selective S1Preceptor agonist
#9 | 2017-11-09Dosing regimen for a selective S1Preceptor agonist
#10 | 2015-09-24Dosing regimen for a selective S1Preceptor agonist
#11 | 2014-10-23Dosing regimen for a selective S1Pagonist
#12 | 2014-10-23DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST
#13 | 2014-10-09DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST
930952 ⎘